Mursla Bio has published peer-reviewed data showing that isolating liver-derived [...]
A Phase 1/1b clinical trial has begun in Australia to [...]
Ona Therapeutics has appointed Antoine Yver as chair of its [...]
Strategic collaboration combines advanced AAV-like particle technology with targeted oncology [...]